Ernexa Therapeutics, Inc. (ERNA)
0.2851
-0.01
(-4.33%)
USD |
NASDAQ |
Feb 27, 16:00
0.2916
+0.01
(+2.28%)
After-Hours: 20:00
Ernexa Therapeutics Research and Development Expense (TTM) : 4.638M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Ocular Therapeutix, Inc. | 197.10M |
| Quince Therapeutics, Inc. | 28.61M |
| Recursion Pharmaceuticals, Inc. | 425.27M |
| Tango Therapeutics, Inc. | 132.82M |
| Aprea Therapeutics, Inc. | 8.393M |